Drug
Betrixaban Single Dose
Betrixaban Single Dose: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Betrixaban single oral dose NCT01765855 | Phase 1 | Health Volunteers |
Latest
No recent events.
Follow Betrixaban Single Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.